Verve Therapeutics, Inc. short interest in 2025
In 2025, Verve Therapeutics, Inc.'s disclosed short interest ran from 17.47% of shares outstanding on 15 Jan 2025 to 11.09% on 30 Jun 2025, a change of -6.38 percentage points. The year's high was 22.26% on 30 May 2025 and its low 11.09% on 30 Jun 2025, averaging 18.38% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.72 days on 31 Mar 2025. Full history: Verve Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2025 in figures
- Start of year
- 17.47% (15 Jan 2025)
- End of year
- 11.09% (30 Jun 2025)
- Change
- -6.38 pp
- High
- 22.26% (30 May 2025)
- Low
- 11.09% (30 Jun 2025)
- Average
- 18.38%
- Highest days to cover
- 15.72 (31 Mar 2025)
- SEC filings marked
- 4
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 17.47% | 11.29 | |
| 31 Jan 2025 | 15.65% | 6.59 | |
| 14 Feb 2025 | 16.56% | 10.39 | |
| 28 Feb 2025 | 17.56% | 11.02 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 18.04% | 10.61 | |
| 31 Mar 2025 | 19.64% | 15.72 | |
| 15 Apr 2025 | 19.56% | 2.31 | |
| 30 Apr 2025 | 21.87% | 5.33 | |
| 15 May 2025 | 20.65% | 6.20 | 10-Q filed, results (8-K) |
| 30 May 2025 | 22.26% | 7.33 | |
| 13 Jun 2025 | 20.19% | 5.67 | |
| 30 Jun 2025 | 11.09% | 1.00 |
See also: Verve Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.